Heparin prophylaxis in major sclerotherapy (the Prosclep study)
Journal of Theoretical and Applied Vascular Research · 2021
DOI: 10.24019/jtavr.120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Theoretical and Applied Vascular Research, 2021. Verfasst von Alessandro Frullini und 18 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
To study the incidence and the possibility of preventing thrombotic complications during major sclerotherapy for venous insufficiency of lower limbs.
Methods
A total of 2489 sclerotherapy sessions were performed on 2010 patients. 1087 sessions (43.7%) were carried out without heparin prophylaxis while in 1402 sessions (56.3%) a prophylaxis with low molecular weight (LMWH) was used. Thrombotic complications were divided into a) post sclerotherapy transient extension (POSTE) if they consisted of a simple extension of sclerotherapy, and b) deep venous thrombosis (DVT) when the complication occurred in a location separate from that of sclerosis.
Results
The overall incidence of a thrombotic complication was 0.52%. Out of 2489 sessions, 8 cases of POSTE (0.32%) and 5 thromboses of a gastrocnemius vein (0.2%) were diagnosed The most significant figures were reached in the great saphenous vein (GSV) subgroup, where the incidence of complications was 1.91% without prophylaxis and 0.31% (p = 0.009) with prophylactic heparin.
Conclusions
In this study prophylaxis with LMWH significantly reduced the incidence of thrombotic complications when sclerotherapy of the great saphenous vein was performed.
Zitieren
APA
Frullini, A., Giannetta, P., Guarnaccia, D., Loparco, O. W., Lucca, E. P., Mancini, D., Ravagli, C., Rendace, M., Paradiso, S., Rosi, G., Pavei, P., Albano, P., Casoni, P., Cavallini, A., Cristiani, A., D'Ascanio, C., Forzanini, M., Fruttini, D., & Gerardi, G. A. (2021). Heparin prophylaxis in major sclerotherapy (the Prosclep study). Journal of Theoretical and Applied Vascular Research. https://doi.org/10.24019/jtavr.120
Vancouver
Frullini A, Giannetta P, Guarnaccia D, Loparco OW, Lucca EP, Mancini D, et al. Heparin prophylaxis in major sclerotherapy (the Prosclep study). Journal of Theoretical and Applied Vascular Research. 2021. doi:10.24019/jtavr.120
BibTeX
@article{Frullini2021,
author = {Frullini, Alessandro and Giannetta, Piero and Guarnaccia, Demetrio and Loparco, Oronzo Walter and Lucca, Edy Pablo and Mancini, Donato and Ravagli, Claudio and Rendace, Michele and Paradiso, Sabino and Rosi, Gianluigi and Pavei, Patrizia and Albano, Paolo and Casoni, Paolo and Cavallini, Alvise and Cristiani, Alfonso and D'Ascanio, Camillo and Forzanini, Mario and Fruttini, Daniela and Gerardi, Gaspare Andrea},
title = {Heparin prophylaxis in major sclerotherapy (the Prosclep study)},
journal = {Journal of Theoretical and Applied Vascular Research},
year = {2021},
doi = {10.24019/jtavr.120}
}
EUVIMED